Symposium on Imaging Agents and Molecular Beacons

显像剂和分子信标研讨会

• 批准号: 6760632
• 负责人: Samuel Achilefu
• 金额: $ 2.3万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-02-15 至 2004-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6760632
• 关键词: bioimaging /biomedical imaging; magnetic resonance imaging; meeting /conference /symposium; molecular probes; nuclear magnetic resonance spectroscopy; travel

DESCRIPTION (provided by applicant): Imaging agents play a vital role in the diagnosis and management of a variety of human diseases. With recent advances in molecular biology, there is a need to develop new imaging agents that respond to physiopathological events at the molecular level. This is within the purview of chemists who are trained to design molecules for specific applications. While many conferences on molecular imaging are held every year, the focus had not been on the strategy to develop imaging agents that are crucial in molecular imaging of diseases. Consequently, we plan to organize a chemistry-focused symposium to exchange ideas on the recent advances in the chemistry and application of imaging agents in biomedical research and clinical settings. To harness the power of the world's largest chemist organization, the American Chemical Society (ACS), to attract a large audience, we plan to hold the symposium in conjunction with the ACS National Meeting held at Anaheim, CA from March 28 to April 1, 2004. Five sessions will be held and will cover topics on nuclear, magnetic resonance, ultrasound, radiographic, optical and miscellaneous imaging agents for medical applications.

描述（由申请人提供）： 成像剂在各种人类疾病的诊断和管理中起着至关重要的作用。随着分子生物学的最新进展，有必要开发新的成像剂，以应对分子水平的生理病理事件。这是在化学家的权限范围内，他们接受了为特定应用设计分子的培训。尽管每年举行许多关于分子成像的会议，但重点并不是在开发疾病分子成像至关重要的成像剂的策略上。因此，我们计划组织以化学为重点的研讨会来交换成像剂在生物医学研究和临床环境中化学和应用的最新进展的想法。为了利用世界上最大的化学组织美国化学学会（ACS）的力量吸引大量听众，我们计划与3月28日至4月1日在加利福尼亚州阿纳海姆举行的ACS全国会议一起举行研讨会。 2004年。将举行五个会议，并将涵盖有关医疗应用的核，磁共振，超声，放射线，光学和其他成像剂的主题。